370 related articles for article (PubMed ID: 23728176)
1. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
Nemlich Y; Greenberg E; Ortenberg R; Besser MJ; Barshack I; Jacob-Hirsch J; Jacoby E; Eyal E; Rivkin L; Prieto VG; Chakravarti N; Duncan LM; Kallenberg DM; Galun E; Bennett DC; Amariglio N; Bar-Eli M; Schachter J; Rechavi G; Markel G
J Clin Invest; 2013 Jun; 123(6):2703-18. PubMed ID: 23728176
[TBL] [Abstract][Full Text] [Related]
2. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing.
Ota H; Sakurai M; Gupta R; Valente L; Wulff BE; Ariyoshi K; Iizasa H; Davuluri RV; Nishikura K
Cell; 2013 Apr; 153(3):575-89. PubMed ID: 23622242
[TBL] [Abstract][Full Text] [Related]
3. ADAR1p150 regulates the biosynthesis and function of miRNA-149* in human melanoma.
Yujie Ding MM; Shi X; Ji J; Su Y
Biochem Biophys Res Commun; 2020 Mar; 523(4):900-907. PubMed ID: 31959472
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic and stimulative roles of ADAR1 in RNA silencing.
Nishikura K; Sakurai M; Ariyoshi K; Ota H
RNA Biol; 2013 Aug; 10(8):1240-7. PubMed ID: 23949595
[TBL] [Abstract][Full Text] [Related]
5. ADAR1-mediated regulation of melanoma invasion.
Nemlich Y; Baruch EN; Besser MJ; Shoshan E; Bar-Eli M; Anafi L; Barshack I; Schachter J; Ortenberg R; Markel G
Nat Commun; 2018 May; 9(1):2154. PubMed ID: 29855470
[TBL] [Abstract][Full Text] [Related]
6. A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.
Galore-Haskel G; Nemlich Y; Greenberg E; Ashkenazi S; Hakim M; Itzhaki O; Shoshani N; Shapira-Fromer R; Ben-Ami E; Ofek E; Anafi L; Besser MJ; Schachter J; Markel G
Oncotarget; 2015 Oct; 6(30):28999-9015. PubMed ID: 26338962
[TBL] [Abstract][Full Text] [Related]
7. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
8. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
RamÃrez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
9. ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.
Kim HS; Na MJ; Son KH; Yang HD; Kim SY; Shin E; Ha JW; Jeon S; Kang K; Moon K; Park WS; Nam SW
Exp Mol Med; 2023 Jan; 55(1):95-107. PubMed ID: 36599932
[TBL] [Abstract][Full Text] [Related]
10. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
11. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.
Wang Q; Hui H; Guo Z; Zhang W; Hu Y; He T; Tai Y; Peng P; Wang L
RNA; 2013 Nov; 19(11):1525-36. PubMed ID: 24067935
[TBL] [Abstract][Full Text] [Related]
14. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
Shoshan E; Mobley AK; Braeuer RR; Kamiya T; Huang L; Vasquez ME; Salameh A; Lee HJ; Kim SJ; Ivan C; Velazquez-Torres G; Nip KM; Zhu K; Brooks D; Jones SJ; Birol I; Mosqueda M; Wen YY; Eterovic AK; Sood AK; Hwu P; Gershenwald JE; Robertson AG; Calin GA; Markel G; Fidler IJ; Bar-Eli M
Nat Cell Biol; 2015 Mar; 17(3):311-21. PubMed ID: 25686251
[TBL] [Abstract][Full Text] [Related]
15. Processing of
Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K
RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447
[TBL] [Abstract][Full Text] [Related]
16. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
[TBL] [Abstract][Full Text] [Related]
17. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
18. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
19. ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.
Chen T; Xiang JF; Zhu S; Chen S; Yin QF; Zhang XO; Zhang J; Feng H; Dong R; Li XJ; Yang L; Chen LL
Cell Res; 2015 Apr; 25(4):459-76. PubMed ID: 25708366
[TBL] [Abstract][Full Text] [Related]
20. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
